GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
Carlos ALEMPARTE-GALLARDO,Lourdes ENCINAS,Jorge ESQUIVIAS PROVENCIO
申请号：
US16639163
公开号：
US20200231555A1
申请日:
2018.08.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by Mycobacterium, such as tuberculosis.
